Progressive Goal Attainment Program for Veterans

NCT01565863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2020-06-11

No results posted yet for this study

Summary

The purpose of this study is to test the effectiveness of the Progressive Goal Attainment Program (PGAP) in improving employment outcomes and community engagement among U.S. veterans with disabilities.

Conditions

  • Mental Disorders
  • Worries; Pain or Disability

Interventions

BEHAVIORAL

Progressive Goal Attainment Program

The Progressive Goal Attainment Program (PGAP) is a behavioral intervention originally developed in Canada at McGill University in order to increase return to work and community integration for individuals who receive worker's compensation. PGAP is the first disability program that is specifically designed to target the psycho-social risk factors of disability. The premise behind PGAP is that inactivity and attitudinal barriers increase work disability, and these issues are a primary cause of unemployment for individuals with physical and mental disabilities. PGAP is a structured, 10-week intervention that focuses upon helping clients develop a planned activity schedule to assist them in resuming desirable life activities.

Sponsors & Collaborators

  • VA Connecticut Healthcare System

    collaborator FED
  • Michael E. DeBakey VA Medical Center

    collaborator FED
  • The Boeing Company

    collaborator INDUSTRY
  • Bristol-Myers Squibb

    collaborator INDUSTRY
  • The Community Foundation for Greater New Haven

    collaborator UNKNOWN
  • Disabled American Veterans

    collaborator OTHER
  • MDRC

    lead OTHER

Principal Investigators

  • Peter Baird · MDRC

  • Jack Tsai · VA Connecticut Healthcare System

  • Anthony Kerrigan · Michael E. DeBakey VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-06-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01565863 on ClinicalTrials.gov